Strategy (MSTR), a U.S.-based business intelligence firm, is set to release its Q1 2025 earnings results on May 1. Wall Street analysts anticipate a loss of $1.37 per share and revenues of $116.6 ...

Discover key takeaways from FTC Solar's Q1 2025 earnings: 58% revenue growth, expanded backlog, and a breakthrough 1P tracker driving market gains.

Discover X4 Pharmaceuticals' Q1 2025 updates, including mavorixafor's $1-2B U.S. market potential, trial progress, and WHIM syndrome commercialization.

In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that it has entered into a definitive agreement with a single institutional investor for the purchase and sale of ...

Though insider buying has slowed during the first-quarter reporting season, some insiders continued to build stakes or bucked ...

OmniAb, Inc. today announced that management will be participating in five investor conferences over the coming weeks. H.C. Wainwright 1st Annual Royalty Company Virtual Conference, May 13. Management ...

H.C. Wainwright initiated coverage at ‘Buy’ and a $480 price target earlier this week, citing its aggressive Bitcoin ...

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the ...